ATE231167T1 - Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper - Google Patents

Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper

Info

Publication number
ATE231167T1
ATE231167T1 AT95941870T AT95941870T ATE231167T1 AT E231167 T1 ATE231167 T1 AT E231167T1 AT 95941870 T AT95941870 T AT 95941870T AT 95941870 T AT95941870 T AT 95941870T AT E231167 T1 ATE231167 T1 AT E231167T1
Authority
AT
Austria
Prior art keywords
thymidine phosphorylase
human
monoclonal antibody
growth factor
cell growth
Prior art date
Application number
AT95941870T
Other languages
English (en)
Inventor
Kazutaka Miyadera
Yuji Yamada
Yuji Takebayashi
Shin-Ichi Akiyama
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE231167T1 publication Critical patent/ATE231167T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95941870T 1994-12-28 1995-12-25 Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper ATE231167T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32732894A JP3268147B2 (ja) 1994-12-28 1994-12-28 モノクローナル抗体
PCT/JP1995/002661 WO1996020217A1 (en) 1994-12-28 1995-12-25 Monoclonal antibody

Publications (1)

Publication Number Publication Date
ATE231167T1 true ATE231167T1 (de) 2003-02-15

Family

ID=18197918

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941870T ATE231167T1 (de) 1994-12-28 1995-12-25 Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper

Country Status (8)

Country Link
US (1) US5798213A (de)
EP (1) EP0749981B1 (de)
JP (1) JP3268147B2 (de)
AT (1) ATE231167T1 (de)
AU (1) AU4315396A (de)
DE (1) DE69529405T2 (de)
ES (1) ES2191722T3 (de)
WO (1) WO1996020217A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1444521A4 (de) * 2001-09-17 2006-12-06 Univ Texas Verfahren und zusammensetzungen unter beteiligung von thymidinphosphorylase als marker für hiv-infektion, den verlauf von aids und arzneistoffresistenz
EP3067698A1 (de) 2015-03-11 2016-09-14 Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Pd-ecgf als biomarker für krebs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227302A (en) * 1988-12-20 1993-07-13 Ludwig Institute For Cancer Research DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
ES2191722T3 (es) 2003-09-16
EP0749981A4 (de) 2000-03-08
DE69529405T2 (de) 2003-10-30
JPH08183800A (ja) 1996-07-16
AU4315396A (en) 1996-07-19
WO1996020217A1 (en) 1996-07-04
JP3268147B2 (ja) 2002-03-25
EP0749981A1 (de) 1996-12-27
DE69529405D1 (en) 2003-02-20
EP0749981B1 (de) 2003-01-15
US5798213A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
US4636463A (en) Antibodies to human interleukin-2 induced by synthetic polypeptides
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
ATE366747T1 (de) Menschliche monoklonale antikörper gegen den epidermalen wachstumsfaktorrezeptor
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
EP0619841A4 (de) T-cadherin-bindungsmolekül.
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE69807679D1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
ATE159727T1 (de) Kleinste erkennungseinheit eines pem-mucin- ''tandem repeat''-spezifischen monoklonalen antikoerpers
DE69309906D1 (de) Behandlung für entzündungserkrankung des darmes
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
ATE112783T1 (de) Stressprotein aus bakterien.
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
EP0725081A4 (de) MONOKLONALER ANTIKÖRPER GEGEN MxA DES MENSCHLICHEN Mx PROTEINS
ATE397659T1 (de) Polyklonale antikörper gegen den menschlichen alpha-pdgf-rezeptor und dessen verwendung
ES2179824T3 (es) Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
DE69216600D1 (de) Synthetisches CDw52(CAMPATH-1) Peptidantigen
FI925321A0 (fi) Immunodiagnostiskt ledinflammationstest
DE69529405D1 (en) Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
FR2718849B1 (fr) Procédé d'immunodosage de l'antithrombine III activée par un glycosaminoglycane, anticorps monoclonaux correspondants et leur procédé d'obtention.
DE69332583D1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
US4771125A (en) Human soluble immune response suppressor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0749981

Country of ref document: EP

REN Ceased due to non-payment of the annual fee